Abstract
Three characteristics define a substance as a blood group antigen. First, the substance is present in the blood, most commonly on the blood cells, but often also in the blood plasma. Substances present exclusively in the plasma and other body fluids are usually not included in the category of blood group antigens. Of the blood cells, the erythrocyte is generally the type locality, the site at which an antigen was originally detected. Although leukocyte and platelet antigens are not excluded from the blood group antigen category, their coverage is usually relegated, both for historical and practical reasons, to separate compendia. Historically, erythrocyte antigens were the first to be described, the existence of leukocyte and platelet antigens was reported much later. The leukocyte antigens — now largely assigned either to the major histocompatibility complex (Mhc) or the cluster of differentiation (CD) series — have become so numerous and their characterization so extensive that justice can be done to them only by separating them from the erythrocyte antigens. Second, to qualify as a blood group antigen, a substance must be capable of eliciting an immune response, usually of the humoral type. Some blood group antigens (e.g., those of the ABO, H, Lewis systems) can probably induce only humoral responses, whereas others (e.g. those of the Rh, MNS, Luteran, Kell, Duffy, Kidd, Diego, and other systems) have at least the potential of also eliciting T lymphocyte-based cellular responses. The prevailing reliance on the humoral response has dictated the use of techniques based almost exclusively on antibody reactions. Serology remains to this day emblematic of blood group antigen studies, although in the future it will probably be replaced either entirely, or at least to a large extent, by molecular biology techniques. Third, the genes encoding blood group antigens are polymorphic so that some individuals of a species possess one form of the antigen and others another. This characteristic is the necessary condition for elicitation of immune response against the antigen which is commonly of the allogeneic type. The blood group antigens are, with few exceptions, alloantigens.
This concluding chapter of the blood group antigen part of this book draws heavily on the information described in the preceding contributions. In the interest of brevity, references have been restricted to a minimum; for complete documentation of the discussed findings, the reader is referred to the relevant chapters.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arce MA, Thompson ES, Wagner S, Coyne KE, Ferdman BA, Lublin DM. Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood 82: 651–655, 1993
Bailly P, Hermand P, Callebaut I, Sonneborn HH, Khamlichi S, Mornon JP, Cartron JP. The LW blood group glycoprotein is homologous to intercellular adhesion molecules. Proc Natl Acad Sci USA 91: 5306–5310, 1994
Blancher A, Socha WW. The ABO Hh and Lewis blood group in man and nonhuman primates. In: Blancher A, Klein J, Socha WW (eds) Molecular biology and evolution of blood group and MHC antigens in primates. Springer, Berlin Heidelberg New York, pp. 30–92, 1997a
Blancher A, Socha WW. The Rhesus system and its counterparts in nonhuman primates. In: Blancher A, Klein J, Socha WW (eds) Molecular biology and evolution of blood group and MHC antigens in primates. Springer, Berlin Heidelberg New York, pp. 147–219, 1997b
Brandon EP, Idzerda RL, McKnight GS. Targetting the mouse genome: a compendium of knockouts. Curr Biol 5: 569–694; 627–634; 873–881, 1995
Cherif-Zahar B, Bloy C, Van Kim C, Blanchard D, Bailly P, Hermand P, Salmon C, Cartron JP, Colin Y. Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc Natl Acad Sci USA 87: 6243–6247, 1990
Daniels GL, Moulds JJ, Anstee DJ, Bird GWG, Brodheim E, Cartron JP, Dahr W, Engelfriet CP, Issitt PD, Jorgensen J, Kornstad L, Lewis M, Levene C, Lubenko A, Mallory D, Morel P, Nordhagen R, Okubo Y, Reid M, Rouger P, Salmon C, Seidl S, Sistonen P, Wendel S, Woodfield G, Zelinski T. ISBT working party on terminology for red cell surface antigens. Sao Paulo report. Vox Sang 65: 77–80, 1993
Feldman MW, Nabholz M, Bodmer WF. Evolution of the Rh polymorphism: a model for the interaction of incompatibility, reproductive compensation, and heterozygote advantage. Am J Hum Genet 21: 171–193, 1969
Frattali AF, Spitalnik SL. Blood group antigens as receptors for pathogens. In: Blancher A, Klein J, Socha WW (eds) Molecular biology and evolution of blood group and MHC antigens in primates. Springer, Berlin Heidelberg New York, pp. 268–304, 1997
Goelz SE, Hession C, Goff D, Griffiths B, Tizard R, Newman B, Chi-Rosso G, Lobb R.: A gene that directs the expression of an ELAM-1 ligand. Cell 63: 1349–1356, 1990
Haldane JBS. Mutation and the Rhesus reaction. Nature 153: 106, 1944
Hochgeschwender U, Brennan MB. Rendundant genes? Nat Genet 8: 219–220, 1994
Kajii E, Umenishi F, Iwamoto S, Ikemoto S. Isolation of a new cDNA clone encoding an Rh polypeptide associated with the Rh blood group system. Hum Genet 91: 157–162, 1993
Kawaguchi H, O’hUigin C, Klein J. Evolution of primate C4 and CYP21 genes. In: Klein J, Klein D (eds) Molecular evolution of the major histocompatibility complex. Springer, Berlin Heidelberg New York, pp 357–381, 1991
Kelly RJ, Roquier S, Giorgi D, Lennon GG, Lowe JB. Sequence and expression of a candidate for the human Secretor blood group α(1,2) fucosyltransferase gene (FUT 2 ); homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem 270: 4640–4649, 1995
Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16: 111–120, 1980
Klein J. Generation of diversity at MHC loci: Implications for T-cell receptor repertoires. In: Fougereau M, Dausset J (eds) Immunology, vol 80. Academic, London, pp 239–253, 1980
Klein J. Origin of major histocompatibility complex polymorphism: the trans-species hypothesis. Hum Immunol 19: 155–162, 1987
Klein J, Satta Y, O’hUigin C, Takahata N. The molecular descent of the major histocompatibility complex. Annu Rev Immunol 11: 269–295, 1993
Kominato Y, McNeill PD, Yamomoto M, Russell M, Hakomori S, Yamomoto F. Animal histo-blood group ABO genes. Biochem Biophys Res Comm 189: 154–164, 1992
Kukowska-Latallo JF, Larsen RD, Nair RP, Lowe JB. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α(1,3/1,4) fucosyltransferase. Genes Dev 4: 1288–1303, 1990
Kumar S, Tamura K, Nei M. MEGA: molecular evolutionary genetic analysis version i.o. Pennsylvania State University, University Park, PA, 1993
Larsen RD, Ernst LK, Nair RP, Lowe JB. Molecular cloning sequence and expression of a human GDP-L-fucose:β-D-galactoside 2-α-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc Natl Acad Sci USA 87: 6674–6678, 1990
Le Van Kim C, Cherif-Zahar B, Raynal V, Mouro I, Lopez M, Cartron JP, Colin Y. Multiple Rh mRNAs isoforms are produced by alternative splicing. Blood 8o: 1074–1078, 1992
Le Van Kim C, Mouro I, Cherif-Zahar B, Raynal V, Cherrier C, Cartron JP, Colin Y. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci USA 89: 10925–10929, 1992
Levin BR. The effect of reproductive compensation on the long term maintenance of the Rh-polymorphism: the Rh crossroad revisited. Am J Hum Genet 19: 288–302, 1967
Li CC. Is the Rh facing a crossroad? A critique of the compensation effect. Am Nat 87: 257–261, 1953
Martinko JM, Vincek V, Klein D, Klein J. Primate ABO glycosyltransferases: evidence for trans-species evolution. Immunogenetics 37: 274–278, 1993
Natsuka S, Gersten KM, Zenita K, Kannagi R, Lowe JB. Molecular cloning of a cDNA encoding a novel human leukocyte α-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis determinant. J Biol Chem 269: 16789–16794, 1994
Nei M. Molecular evolutionary genetics. Columbia University Press, New York, 1987
Nei M, Li W-H, Tajima F, Narain P. Polymorphism and evolution of the Rh blood groups. Jpn J Hum Genet 26: 263–278, 1981
Parsons SF, Mallinson G, Holmes CH, Houlihan JM, Simpson KL, Mawby WJ, Spurr NK, Warne D, Barclay AN, Anstee DJ. The Lutheran blood group glycoprotein, another member of the immunoglobulin superfamily, is widely expressed in human tissues and is developmentally regulated in human liver. Proc Natl Acad Sci USA 92: 5496–5500, 1995
Paulson JC, Colley KJ. Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem 264: 17615–17618, 1989
Piau JP, Labarriere N, Dabouis G, Denis MG. Evidence for two distinct α(1,2)-fucosyltransferase genes differentially expressed throughout the rat colon. Biochem J 300: 623–626, 1994
Race RR. Some recent observations on the inheritance of blood groups. Br Med Bull 2: 160–165, 1944
Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406–425, 1987
Salvignol I, Blancher A, Calvas P, Clayton J, Socha WW, Colin Y, Ruffle J. Molecular genetics of chimpanzee Rh-related genes: their relationship with the R-C-E-F blood group system, the chimpanzee counterpart of the human rhesus system. Biochem Genet 32: 201–221, 1994
Schenkel-Brunner H. Human blood groups. Chemical and biochemical basis of antigen specificity. Springer, Vienna New York, 1995
Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673–4680, 1994
Weston BW, Nair RP, Larsen RD, Lowe JB. Isolation of a novel human α(1,3) fucosyltransferase gene and molecular comparison to the human Lewis blood groups α(1,3/1,4) fucosyltransferase gene. J Biol Chem 267: 4152–4160, 1992a
Weston BW, Smith PL, Kelly RJ, Lowe JB. Molecular cloning of a fourth member of a human α(1,3) fucosyltransferase gene family: multiple homologous sequences that determine expression of the Lewis x, sialyl Lewis x, and difucosyl sialyl Lewis x epitopes. J Biol Chem 267: 24574–24584, 1992b
Yamamoto FI. Molecular genetics of the ABO histo-blood group system. Vox Sang 69: 1–7, 1995
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Klein, J., O’hUigin, C., Blancher, A. (1997). Evolution of Blood Group Antigen Polymorphism. In: Blancher, A., Klein, J., Socha, W. (eds) Molecular Biology and Evolution of Blood Group and MHC Antigens in Primates. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59086-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-59086-3_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63843-5
Online ISBN: 978-3-642-59086-3
eBook Packages: Springer Book Archive